Gamma Knife Market Trends, Application Analysis and Growth Rate
by Susan Hill Business ConsultantThe global gamma knife
market is
expected to reach USD 239.2 million by 2025, according to a new report by Grand
View Research, Inc. Increasing prevalence of cancer, brain tumors, and other
neurological diseases, rising adoption of these instruments in surgery centers,
growing preference for Minimally Invasive Surgeries (MIS), and technological
advancements in the device are amongst few factors expected to drive the
market.
Gamma knife therapy is used for treatment of various
brain and neurological disorders such as brain tumors, brain metastases,
epilepsy, and arteriovenous malformations. Demand for these instruments in
surgery centers is growing due to their various advantages such as safety,
micro precision, lack of postsurgical complications, and lack of incisions.
Technological advancements have improved precision in
surgery. For instance, upgradation of Leksell Gamma Knife models U, B, C/4C,
and Perfexion to Icon provided micro precision in surgery and boosted adoption
of this device in surgery centers. According to reports published by Elekta AB,
approximately 70,000 patients undergo gamma knife surgery each year. This
number is expected to increase over the forecast period owing to rising
prevalence of target diseases and increasing preference for MIS.
In addition, growing demand for MIS over open
surgeries is one of the key factors responsible for increasing adoption of this
therapy. Gamma knife treatment procedure results in fewer traumas and faster
recovery as compared to open surgeries. It helps reduce hospital stays, thus
ensuring economic viability and reduction in medical expenses. Lack of
incisions and postsurgical complications are key factors responsible for
boosting demand for minimally invasive surgeries.
Further
Key Findings from the Report Suggest:
- Global gamma knife market size was estimated at USD 171,505.7
thousand in 2016 and is expected to grow at a CAGR of around 3% from 2017
to 2025
- Malignant tumors emerged as the largest segment and the ocular
diseases segment is anticipated to witness fastest growth over the next 8
years
- The Asia Pacific region is anticipated to witness lucrative growth
over the next decade owing to rising incidence of cancer, developments in
healthcare infrastructure, and rapid economic development across major
emerging economies. It is expected to grow at a CAGR of around 4% over the
forecast period
- Elekta AB is the only player operating in this market since Gamma
Knife is a patent-protected trademark product of the company.
Access
full research report on global gamma knife market:
www.grandviewresearch.com/industry-analysis/gamma-knife-market
Sponsor Ads
Created on Aug 28th 2019 04:41. Viewed 297 times.